This article presents a review of recent advances in neuroscience research in the specific
area of brain connectivity as a potential biomarker of Alzheimer's disease with a focus on the …

Repetitive transcranial magnetic stimulation (rTMS) is emerging as a non-invasive
therapeutic strategy in the battle against Alzheimer's disease. Alzheimer's disease patients …

Recent resting-state functional magnetic resonance imaging (rs-fMRI) studies have provided
strong evidence of abnormal spontaneous brain activity in amnestic mild cognitive …

Alzheimer's disease is an incurable, progressive neurological brain disorder. Earlier
detection of Alzheimer's disease can help with proper treatment and prevent brain tissue …

Background: Imaging studies in Alzheimer's disease (AD) have yet to answer the underlying
questions concerning the relationship among tau retention, neuroinflammation, network …

Alzheimer's disease (AD) is a degenerative condition of the brain that affects the memory
and reasoning abilities of patients. Memory is steadily wiped out by this condition, which …

Resting‐state functional magnetic resonance imaging (rs‐fMRI) has the potential to shed
light on the pathophysiological mechanisms of Huntington's disease (HD), paving the way to …

Abstract Background In Alzheimer's disease (AD), pathological changes may arise up to 20
years before the onset of dementia. This pre-dementia window provides a unique …

The role of the cerebellum in cognitive function has been broadly investigated in the last
decades from an anatomical, clinical, and functional point of view and new evidence points …

Alzheimer's disease is dementia that impairs one's thinking, behavior, and memory. It starts
as a moderate condition affecting areas of the brain that make it challenging to retain …